CNR1 and Alzheimer disease: In endogenous cannabinoid-related studies, 2-AG has been reported to activate PPAR-γ (peroxisome proliferator-activated receptor-γ) and induce CB1R-dependent anti-inflammatory and neuroprotective effects in response to pro-inflammatory impairments in the neuropathology of Alzheimer’s disease [73] (Figure 2).